Hanne Damgaard Jensen

Direttore operativo presso CURASIGHT A/S

Patrimonio netto: 5 605 $ in data 31/05/2024

Health Technology

Consumer Services

Relazioni attive

Nome	Sesso	Età	Società collegate	Collaborazione
Jan van de Winkel	M	63	GENMAB A/S	25 anni
Andreas Kjaer	M	61	CURASIGHT A/S	11 anni
Ulrich Krasilnikoff	M	57	CURASIGHT A/S	8 anni
Carsten Nielsen	M	41	CURASIGHT A/S	11 anni
Per Falholt	M	65	CURASIGHT A/S	4 anni
Jacob Madsen	M	52	CURASIGHT A/S	11 anni
Henrik Ehlers Wulff	M	54	NOVO NORDISK A/S	25 anni
Karsten Munk Knudsen	M	53	NOVO NORDISK A/S	25 anni
Charlotte Vedel	M	56	CURASIGHT A/S	4 anni
Anthony Pagano	M	46	GENMAB A/S	17 anni
Lars Trolle	M	57	CURASIGHT A/S	10 anni
Martine van Vugt	M	71	GENMAB A/S	23 anni
Camilla Sylvest	F	52	NOVO NORDISK A/S	28 anni
Anders Gersel Pedersen	M	73	GENMAB A/S	21 anni
Birgitte Stephensen	F	63	GENMAB A/S	22 anni
Kirsten Drejer	M	68	CURASIGHT A/S	3 anni
Nic Gillings	M	56	CURASIGHT A/S	-

Mostra altro

Grafico relazionale

Relazione in diverse aziende

Relazioni precedenti

Nome	Sesso	Età	Società collegate	Collaborazione
Michael Blair Widmer	M	76	GENMAB A/S	11 anni
Bo Kruse	M	52	Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark. GENMAB A/S	15 anni
Jakob Riis	M	58	NOVO NORDISK A/S	21 anni
Claus Juan Møller-San Pedro	M	62	Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark. GENMAB A/S	21 anni
Ole Baadsgaard	M	72	GENMAB A/S	-
Christina Hahner	F	-	GENMAB A/S	-
Jesper Brandgaard	M	60	NOVO NORDISK A/S	20 anni
Karsten Havkrog Pedersen	M	74	GENMAB A/S	11 anni
David Kauffmann	M	-	Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark.	5 anni
Burt Malkiel	M	90	GENMAB A/S	11 anni
Tom Vink	M	61	GENMAB A/S	-
Nedjad Losic	M	55	GENMAB A/S	-
Lisa N. Drakeman	M	70	GENMAB A/S	11 anni
Michael K. Bauer	M	60	GENMAB A/S	14 anni
Hans Henrik Munch-Jensen	M	64	GENMAB A/S	8 anni
Patrick Loustau	M	61	NOVO NORDISK A/S	14 anni
Christopher Yallop	M	-	NOVO NORDISK A/S	6 anni
Henrik Poulsen	M	57	NOVO NORDISK A/S	1 anni
Martin Olin	M	55	NOVO NORDISK A/S	4 anni
Per Gullestrup	M	-	Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark.	9 anni
Jan Mikkelsen	M	65	NOVO NORDISK A/S	11 anni
Jens Munch-Hansen	M	69	Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark.	9 anni
Annette Stube	F	57	NOVO NORDISK A/S	11 anni
René Djurup	M	-	NOVO NORDISK A/S	4 anni
Rikke Glahn Ren	F	-	GENMAB A/S	-
Jorgen Petersen	M	-	GENMAB A/S	-
Patrick van Berkel	M	55	GENMAB A/S	9 anni
Anna Héléne Barnekow	F	60	NOVO NORDISK A/S	2 anni
Gitte L. Pedersen	F	61	NOVO NORDISK A/S	10 anni
Zaiton binti Jamaluddin	F	65	NOVO NORDISK A/S	8 anni
Wolfgang Amann	M	-	Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark.	-
Peter Nordkild	M	69	NOVO NORDISK A/S	2 anni
Joseph Fred Yospe	M	66	GENMAB A/S	2 anni
Paul W. H. I. Parren	M	60	GENMAB A/S	16 anni
Christian Hansen	M	58	NOVO NORDISK A/S	7 anni
Anker Gunvald Lundemose	M	63	NOVO NORDISK A/S	4 anni
Peter David Suzdak	M	65	NOVO NORDISK A/S	7 anni
Donald Lee Drakeman	M	70	GENMAB A/S	-
Jan Ulf Sigvar J. Johansson	M	79	NOVO NORDISK A/S	7 anni
Bruce Carter	M	80	NOVO NORDISK A/S	4 anni
Jan Öhrström	M	67	NOVO NORDISK A/S	9 anni
Peter James Arthur Benson	M	69	Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark.	2 anni
Bo Jesper Hansen	M	66	Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark.	5 anni
Christian Gröndahl	M	60	NOVO NORDISK A/S	14 anni
Annarie Lyles	M	63	GENMAB A/S	-
Florian Schönharting	M	55	GENMAB A/S	-
Jens Jesper Ovesen	M	67	NOVO NORDISK A/S	4 anni
Finn M. Ulrich	M	-	NOVO NORDISK A/S	8 anni
Per Toft Valstorp	M	75	NOVO NORDISK A/S	14 anni
Michael Wolff Jensen	M	53	GENMAB A/S	3 anni
Thomas Feldthus	M	64	NOVO NORDISK A/S	3 anni
Valeta A. Gregg	M	72	NOVO NORDISK A/S	5 anni
Peder Holk Nielsen	M	67	NOVO NORDISK A/S	5 anni
Jette Traulsen	M	-	NOVO NORDISK A/S	5 anni
Joan Schmidt	F	60	NOVO NORDISK A/S	20 anni

Statistiche

Paese	Relazioni	% del totale
Danimarca	72	100.00%

Età delle relazioni

Attive

Scorse

Uomo

Donna

Amministratori

Dirigenti

Provenienza delle relazioni